Anavex Life Sciences Corp (AVXL)

[drv17]

Bio- I would assume that Biogen would not have input as to when they present. It should be up to the AAIC committee (IMO) to schedule unless AAIC can be influenced like the FDA.
If both Anavex and Biogen have Late Breaking Presentations the committee would have the presentations in advance to assess. I would think it is the committe's responsibility to schedule so that the conference attendees obtain the maximum benefit.